TrialCirculation2019

Effects of Canagliflozin on Heart Failure Outcomes Associated With Preserved and Reduced Ejection Fraction in Type 2 Diabetes Mellitus.

Gemma A Figtree et al.PubMed ↗Publisher ↗

No numbers read from the abstract.